Central Indiana Cancer Centers CICC - South — Indianapolis, Indiana

Central Indiana Cancer Centers CICC - South is a clinical research site located in Indianapolis, Indiana, United States 46227.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Central Indiana Cancer Centers CICC - South has participated in 1 clinical trials.

Therapeutic areas: Carcinoid Tumor, Malignant Carcinoid Syndrome.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Central Indiana Cancer Centers CICC - South?

Central Indiana Cancer Centers CICC - South has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Central Indiana Cancer Centers CICC - South conducted?

Central Indiana Cancer Centers CICC - South has 1 clinical trials on record. Their work covers Carcinoid Tumor, Malignant Carcinoid Syndrome.

Is Central Indiana Cancer Centers CICC - South accredited by Crixeo Health?

Central Indiana Cancer Centers CICC - South has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Central Indiana Cancer Centers CICC - South?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.